The latest publication from BIOJUME ‘Sex-specific Disease Modifiers in Juvenile Myoclonic Epilepsy’ has been published in the journal Scientific Reports. You can read the full paper here:
The press release from King’s College London and comment from the paper’s first author, Amy Shakeshaft, can be found here:
In short, the paper shows that treatment response varies according to patient subgroups, with women faring worst of all. The study also sheds light on the problem of stress-triggered seizures, which the consortium are keen to pursue in future work.